首页> 美国卫生研究院文献>Clinical Molecular Pathology >Evaluation of the pre-S (pre-S(1)Ag/pre-S(2)Ab) system in hepatitis B virus infection.
【2h】

Evaluation of the pre-S (pre-S(1)Ag/pre-S(2)Ab) system in hepatitis B virus infection.

机译:在乙型肝炎病毒感染中对pre-S(pre-S(1)Ag / pre-S(2)Ab)系统进行评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The diagnostic and prognostic value of pre-S(1)Ag and pre-S(2)Ab was investigated in 69 HBsAg surface antigen positive patients--14 with acute hepatitis B, 30 with chronic liver disease (six chronic persistent hepatitis, 14 chronic active hepatitis, 10 with cirrhosis) and in 25 asymptomatic carriers. Pre-S(1)Ag was found in all patients with chronic hepatitis B virus (HBV) infection regardless of viral replication. In contrast, pre-S(2)Ab was not detected in any patients. Acute hepatitis was studied sequentially with periodic controls at 20 day intervals. Pre-S(1)Ag cleared before HBsAg in six of 14 (43%) patients who progressed favourably, and the two antigens cleared simultaneously in eight of 14 (57%) cases. Patients with early clearance of pre-S(1)Ag progressed favourably, thus indicating the prognostic value of this test, which, however, is still of limited practical application given the small temporal difference between the moment of clearance of the two antigens. The first markers to clear, however, were HBeAg and DNA-HBV, which showed significant differences with respect to the clearance of HBsAg. Moreover, pre-S(2)Ab appeared before HBsAb in 57.1% of our patients and was found in some patients before pre-S(1)Ag and HBsAg had cleared (42.8%), thus allowing complete viral clearance and acute HBV infection to be predicted earlier.
机译:在69例HBsAg表面抗原阳性的-14急性乙型肝炎,30例慢性肝病(6例慢性持续性肝炎,14例HBsAg)中研究了pre-S(1)Ag和pre-S(2)Ab的诊断和预后价值。慢性活动性肝炎,10例肝硬化)和25例无症状携带者。在所有慢性乙型肝炎病毒(HBV)感染的患者中均发现Pre-S(1)Ag,无论病毒复制如何。相反,在任何患者中均未检测到前S(2)Ab。定期对急性肝炎进行研究,每隔20天定期进行一次对照。进展顺利的14例患者中有6例(43%)的Pre-S(1)Ag在HBsAg之前清除,而14例中的8例(57%)的两种抗原同时清除。早期清除pre-S(1)Ag的患者进展良好,因此表明该试验的预后价值,但是,由于两种抗原清除瞬间之间的时间差异很小,因此该方法的实际应用仍然有限。但是,第一个需要清除的标志物是HBeAg和DNA-HBV,它们在清除HBsAg方面显示出显着差异。此外,在我们的57.1%的患者中,pre-S(2)Ab出现在HBsAb之前,并且在某些患者中被发现在pre-S(1)Ag和HBsAg清除之前(42.8%),因​​此可以完全清除病毒并急性感染HBV有待提前预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号